Rose Kay

Rose Kay is a researcher affiliated with the Norwich Medical School at the University of East Anglia (UEA), contributing to academic research in pharmacogenomics and primary care. Her work focuses on the application of genetic testing in clinical settings, particularly for patients managing multiple medications.

Research Interests: Her research spans pharmacogenomics, polypharmacy, personalized medicine, and evidence-based healthcare. She employs systematic review methodologies to evaluate the impact of pharmacogenomic interventions in primary care, aiming to improve patient safety and medication efficacy.

The trend in her scholarly output reflects a strong emphasis on translational research, bridging genomic science with practical clinical implementation, especially in complex patient populations. Her work contributes to the growing field of precision medicine within primary healthcare systems.

Scientific Contributions:

• Active contributor to peer-reviewed systematic reviews in pharmacogenomics.

Advising and Grants: While no formal advisees or grant funding are mentioned in the available text, her collaborative research suggests engagement in academic teams and potential involvement in funded projects related to pharmacogenomics and public health.

Laboratories and Research Teams: Rose Kay is likely part of a research group within the Norwich Medical School focused on nutrition, genetics, and health outcomes, possibly collaborating with researchers such as A.M. Minihane and M. Patel.